Medicines A–Z
L
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
 |
Lidocaine 10% mouth spray | ||
|
Lidocaine 10% spray | ||
|
Lidocaine 4% cream | ||
|
Lidocaine 4% topical solution | ||
 |
Lidocaine 5% patch | For patients who have been treated in line with NICE CG173 Neuropathic pain in adults: pharmacological management in non-specialist settings but are still experiencing neuropathic pain associated with previous herpes zoster infection (post-herpetic neuralgia) |
|
|
Lidocaine and phenylephrine 0.5% | ||
|
Lidocaine hydrochloride | Hospital only |
|
|
Lidocaine hydrochloride with Fluorescein (Minims) | ||
|
Lidocaine with adrenaline (Lignos pan®) | ||
|
Lidocaine with adrenaline (Xylocaine®) |
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.
